These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4776389)

  • 1. [Lienomycin production by strains of Actinomyces vendargensis Struyk et Stheeman, 1957].
    Shvesnikova MA; Maksimova TS; Ol'khovatova OL; Tuliakova TV; Lavrova MF
    Antibiotiki; 1973 Feb; 18(2):102-5. PubMed ID: 4776389
    [No Abstract]   [Full Text] [Related]  

  • 2. [Act. olivovariabilis sp.nov., an organism producing variamycin, a new antitumor antibiotic].
    Rudaia SM; Singal EM; Il'inskaia SA; Solov'eva NK
    Antibiotiki; 1971 Nov; 16(11):969-76. PubMed ID: 4947970
    [No Abstract]   [Full Text] [Related]  

  • 3. [Production of antibiotic 1719 by Actinomyces cinereoviridis sp. nov].
    Korobkova TP; Terekhova LP; Maksimova TS; Kochetkova GV; Ol'khovatova OL
    Antibiotiki; 1972 Aug; 17(8):684-9. PubMed ID: 4564359
    [No Abstract]   [Full Text] [Related]  

  • 4. A search for antitumor substances in the fermentation broths of actinomycetes active against antibiotic-resistant staphylococci.
    Ukleja-Bortkiewicz A; Tyc M; Abgarowicz G; Terlecka J
    Arch Immunol Ther Exp (Warsz); 1967; 15(5):760-4. PubMed ID: 5595077
    [No Abstract]   [Full Text] [Related]  

  • 5. [Production of antineoplastic antibiotic carminomycin by Actinomadura carminata sp.nov].
    Gauze GF; Sveshnikova MA; Ukholina RS; Gavrilina GV; Filicheva VA
    Antibiotiki; 1973 Aug; 18(8):675-8. PubMed ID: 4776400
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of the use of Staphylococcus aureus 209 mutant UV-2 at different stages of screening of new antineoplastic antibiotics].
    Kochetkova GV; Il'chenko GB; Kovsharova IN
    Antibiotiki; 1970 Jul; 15(7):587-90. PubMed ID: 4097990
    [No Abstract]   [Full Text] [Related]  

  • 7. [High molecular weight antineoplastic antibiotics of a polypeptide or protein nature formed by Actinomycetes].
    Kuimova TF
    Antibiotiki; 1966 Jul; 11(7):651-6. PubMed ID: 5997589
    [No Abstract]   [Full Text] [Related]  

  • 8. [Systematic position, variability and antibiotic properties of the producer of antineoplastic antibiotic tavromycetin].
    Ivanitskaia LP; Upiter GD; Sveshnikova MA; Gauze GF
    Antibiotiki; 1966 Nov; 11(11):973-6. PubMed ID: 4871096
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of aurantin on Act. species no. 2, which produces this antibiotic].
    Nefelova MV; Egorov NS
    Antibiotiki; 1971 Jun; 16(6):496-9. PubMed ID: 4106999
    [No Abstract]   [Full Text] [Related]  

  • 10. [Conditions for the formation of the antibiotic rubomycin by the culture Actinomyces coeruleorubidus].
    Manafova NA
    Antibiotiki; 1966 Oct; 11(10):872-7. PubMed ID: 6011841
    [No Abstract]   [Full Text] [Related]  

  • 11. [Conditions for aurantin biosynthesis].
    Nefelova MV
    Mikrobiologiia; 1966; 35(1):35-9. PubMed ID: 4167567
    [No Abstract]   [Full Text] [Related]  

  • 12. [A new producer of mithramycin--Act. atroolivaceus].
    Gauze GF; Maksimova TS; Ukholina RS; Brazhnikova MG; Krugliak EB
    Antibiotiki; 1967 Dec; 12(12):1059-61. PubMed ID: 4970742
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of different methods for the primary selection of antitumor antibiotics].
    Ivanitskaia LP; Upiter GD
    Antibiotiki; 1967 May; 12(5):369-74. PubMed ID: 5627678
    [No Abstract]   [Full Text] [Related]  

  • 14. [New producer of carminomycin, Actinomycer cremeospinus sp. nov].
    Gauze GF; Terekhova LP; Maksimova TS; Ol'khovatova OL; Lavrova NV
    Antibiotiki; 1975 May; 20(5):389-93. PubMed ID: 1225185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antineoplastic effect of antibiotics 3002 and 3853].
    Rossolimo OK; Maksimova TS; Sveshnikova MA; Ol'khovatova OL; Kovsharova IN
    Antibiotiki; 1971; 16(4):320-2. PubMed ID: 5109579
    [No Abstract]   [Full Text] [Related]  

  • 16. [Microorganisms as test-objects in screening programs of antineoplastic antibiotics].
    Kochetkova GV
    Antibiotiki; 1972 Feb; 17(2):172-8. PubMed ID: 4554081
    [No Abstract]   [Full Text] [Related]  

  • 17. [Achievement of C 14 -olivomycin by means of biosynthesis from C 14 -glucose].
    Vatin AE; Karpov VL
    Antibiotiki; 1971 Feb; 16(2):99-103. PubMed ID: 4997524
    [No Abstract]   [Full Text] [Related]  

  • 18. [Carbon and tritium-labeled bruneomycin obtained by biosynthetic method].
    Karpov VL; Romanova LG
    Antibiotiki; 1972 May; 17(5):419-24. PubMed ID: 5032046
    [No Abstract]   [Full Text] [Related]  

  • 19. [Formation of 2 anthracycline antibiotics by the culture related to Act. galilaeus].
    Brazhnikova MG; Kudinova MK; Mezentsev AS; Fedorova GB; Ukholina RS; Kochetkova GV; Maksimova TS; Hechaeva NP; Rossolimo OK
    Antibiotiki; 1968 Nov; 13(11):963-7. PubMed ID: 4976627
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of mutation of T2 phage from h+ to h to screening of antitumor antibiotics produced by actinomycetes.
    Nakamura S; Omura S; Hamada M; Nishimura T; Yamaki H
    J Antibiot (Tokyo); 1967 Jul; 20(4):217-22. PubMed ID: 6072896
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.